E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 4/1/2022 in the Prospect News Emerging Markets Daily.

Moody's cuts Health and Happiness

Moody's Investors Service said it downgraded Health and Happiness (H&H) International Holdings Ltd.'s corporate family rating to Ba3 from Ba2 and senior unsecured rating to B1 from Ba3. Moody's has also changed the outlook to stable from negative.

"The downgrade reflects our expectation that H&H's leverage will stay elevated over the next 12-18 months, post its debt-funded acquisition and amid a continued challenging operating environment," said Shawn Xiong, a Moody's assistant vice president and analyst, in a press release.

"Although the recently announced $1.2 billion refinancing facilities will significantly strengthen H&H's liquidity position, the substantial debt taken as a result of the Zesty Paws acquisition, combined with deterioration in margins, will make the company's deleveraging towards 3.5x-4x unlikely over the next 12 to 18 months," added Xiong.

However, Moody’s does forecast revenue will rise 8%-11% for 2022, and its adjusted EBITDA margin will remain around 15% over the next 12-18 months.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.